Item 5.07 Submission of Matters to a Vote of Security Holders.

On April 23, 2021, GW Pharmaceuticals plc (the "Company") held a meeting of shareholders convened with the permission of the High Court of Justice of England and Wales (the "Court" and, such meeting, the "Court Meeting") and a general meeting of shareholders (the "General Meeting" and, together with the Court Meeting, the "Shareholder Meetings"), in each case in connection with the previously announced transaction whereby Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland, will acquire the entire issued and to be issued share capital of the Company (the "Transaction") pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006 (the "Scheme of Arrangement"). The Company filed its Definitive Proxy Statement for the proposals voted on at the Shareholder Meetings with the Securities and Exchange Commission on March 15, 2021, as supplemented on April 14, 2021 (the "Proxy Statement").

As of 6:00 p.m. (London time) on April 21, 2021, the voting record time for the Shareholder Meetings, the Company's issued share capital consisted of 378,535,952 ordinary shares carrying one vote each. 239,078,361 ordinary shares of the Company were voted by shareholders present in person (including remotely via virtual meeting platform) or by proxy at the Court Meeting. 238,920,196 ordinary shares of the Company were voted by shareholders present in person (including remotely via virtual meeting platform) or by proxy on the special resolution at the General Meeting, and 238,350,664 ordinary shares of the Company were voted by shareholders present in person (including remotely via virtual meeting platform) or by proxy on the ordinary resolution at the General Meeting. All votes at both the Court Meeting and the General Meeting were conducted on a poll.

The final results of voting on each of the items submitted to a vote of the Company's shareholders at the Court Meeting and the General Meeting are set forth below.

The consummation of the Transaction remains subject to closing conditions, including the sanction of the Scheme of Arrangement by the Court.

Court Meeting

Proposal 1: To approve (with or without modification) the Scheme of Arrangement between the Company and the holders of the Scheme Shares (as defined in the Scheme of Arrangement).

The Company's shareholders approved the proposal with the following results:





              % OF SCHEME              % OF SCHEME
    FOR       SHARES FOR    AGAINST   SHARES AGAINST
238,677,167      99.83      401,194        0.17

Of the 251 record shareholders voting on the proposal, 243 record shareholders or 96.81% of those voting voted in favor of the proposal and 8 record shareholders or 3.19% of those voting voted against the proposal.

General Meeting

Special Resolution: To authorize (i) the Board of Directors of the Company to take all action necessary or appropriate for carrying the Scheme of Arrangement into effect and (ii) making certain amendments to the articles of association of the Company in order to facilitate the Transaction.



The Company's shareholders approved the special resolution with the following
results:



    FOR       % FOR   AGAINST   % AGAINST   WITHHELD
238,570,587   99.85   349,609     0.15      250,353

Ordinary Resolution: To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction and the agreements or understandings pursuant to which such compensation may be paid or become payable.

--------------------------------------------------------------------------------

The Company's shareholders approved the ordinary resolution (on a non-binding, advisory basis) with the following results:





    FOR       % FOR    AGAINST     % AGAINST   WITHHELD
141,863,550   59.52   96,487,114     40.48     819,885

Further information regarding each of the foregoing proposals is set forth in the Proxy Statement.




Item 8.01 Other Events.

Results Announcement Press Release

On April 23, 2021 the Company issued a press release announcing the results of the Shareholder Meetings. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Scheme Court Hearing Timing and Attendance

The Court has listed the hearing of the Company's application to sanction the Scheme of Arrangement for May 5, 2021 (the "Scheme Court Hearing"). Details of the Scheme Court Hearing (including the time and name of the Judge) will be available on the Business and Property Courts Rolls Building Cause List (under the heading "Insolvency & Companies Court List (Chancery Division)") at https://www.gov.uk/government/publications/business-and-property-courts-rolls-building-cause-list on the day before the Scheme Court Hearing. This timetable assumes that the Scheme Court Hearing will conclude within a single day and the court order sanctioning the Scheme of Arrangement will be issued on the same day. The dates and times are indicative only and are subject to change. Any shareholder of the Company or other interested party is entitled to attend the Scheme Court Hearing virtually via video conference. Any interested party wishing to receive a link to attend the virtual Scheme Court Hearing and/or to obtain further details in relation to the conduct of the hearing should write to the Chancery Division Listings Office at: chanceryjudgeslisting@justice.gov.uk who will put them in touch with the relevant person. Any Scheme Shareholder (as defined in the Scheme of Arrangement) wishing to make submissions at the Scheme Court Hearing should also write to the Company's solicitors, Slaughter and May, by 12:00 p.m. (London time) on April 29, 2021, at: GWSanctionHearing@slaughterandmay.com.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit Number        Description of Exhibit

99.1                    Press Release, dated April 23, 2021

104                   Cover Page Interactive Data File (embedded within the Inline
                      XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses